Futurebiotics

FlexMend

Serving
4 Tablet(s)
Per container
22
Form
tablet
UPC
049479025046
DSLD
Avoid-flaggedObjective label signals
Flagged excipients
1
1 avoid · 0 caution
FDA recalls
0
no recall history
CAERS reports
3
FDA consumer events
Certifications
0
none recorded
1 avoid-level excipient · Every flag below links to the authority's published citation.

Supplement Facts

4 active ingredients
IngredientAmount% DV
Glucosamine Hydrochloride
UNII · 750W5330FY
1500 mg
OptiMSM
Methylsulfonylmethane
1500 mg
Proprietary Flex Support Compound
Proprietary Blend (Combination)
360 mg
Calories
UNII · 1
23 mg
Flagged excipients

1 flagged · authority citations

  • ● AVOIDTitanium Dioxide
    color

    Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.

FDA CAERS · adverse event context
3
consumer-submitted adverse event reports filed with the FDA CFSAN Adverse Event Reporting System mentioning this product or its brand.

CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →

Other ingredients

Microcrystalline Cellulose · Croscarmellose Sodium · Stearic Acid · Magnesium Stearate · Silicon Dioxide · Ginger Oil · Hydroxypropyl Methylcellulose · Riboflavin · Polyethylene Glycol